Pesquisa | BVS IEC

1.

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.

Rosmarin, David; Passeron, Thierry; Pandya, Amit G; Grimes, Pearl; Harris, John E; Desai, Seemal R; Lebwohl, Mark; Ruer-Mulard, Mireille; Seneschal, Julien; Wolkerstorfer, Albert; Kornacki, Deanna; Sun, Kang; Butler, Kathleen; Ezzedine, Khaled.

N Engl J Med ; 387(16): 1445-1455, 2022 10 20.

Artigo em Inglês | MEDLINE | ID: mdl-36260792

2.

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.

Hammond, Jennifer; Leister-Tebbe, Heidi; Gardner, Annie; Abreu, Paula; Bao, Weihang; Wisemandle, Wayne; Baniecki, MaryLynn; Hendrick, Victoria M; Damle, Bharat; Simón-Campos, Abraham; Pypstra, Rienk; Rusnak, James M.

N Engl J Med ; 386(15): 1397-1408, 2022 04 14.

Artigo em Inglês | MEDLINE | ID: mdl-35172054

3.

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.

Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah; Bowen, Jo; Lydon, Anna; Pedley, Ian; O'Sullivan, Joe M; Birtle, Alison; Gale, Joanna; Srihari, Narayanan; Thomas, Carys; Tanguay, Jacob; Wagstaff, John; Das, Prantik; Gray, Emma; Alzoueb, Mymoona; Parikh, Omi; Robinson, Angus; Syndikus, Isabel; Wylie, James; Zarkar, Anjali; Thalmann, George; de Bono, Johann S; Dearnaley, David P; Mason, Malcolm D; Gilbert, Duncan; Langley, Ruth E; Millman, Robin; Matheson, David; Sydes, Matthew R; Brown, Louise C; Parmar, Mahesh K B; James, Nicholas D.

Lancet ; 399(10323): 447-460, 2022 01 29.

Artigo em Inglês | MEDLINE | ID: mdl-34953525

4.

Why scientists are racing to develop more COVID antivirals.

Kozlov, Max.

Nature ; 601(7894): 496, 2022 01.

Artigo em Inglês | MEDLINE | ID: mdl-35064230

5.

Phase I clinical trial of HC-1119 soft capsule in Chinese healthy adult male subjects: Pharmacokinetics and safety of single-dose proportionality and effects of food.

Ma, Haiping; Xu, Weidong; Ni, Jin; Zhao, Naping; Tang, Shouyan; Li, Song; Cai, Tingting; Xiu, Jianping; Kang, Xin; Gao, Shen; Zhang, Li; Zhou, Tie.

Prostate ; 82(2): 276-285, 2022 02.

Artigo em Inglês | MEDLINE | ID: mdl-34807458

6.

Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.

Yanagisawa, Takafumi; Kimura, Takahiro; Mori, Keiichiro; Suzuki, Hirotaka; Sano, Takayuki; Otsuka, Takashi; Iwamoto, Yuya; Fukuokaya, Wataru; Miyajima, Keiichiro; Enei, Yuki; Sakanaka, Keigo; Matsukawa, Akihiro; Onuma, Hajime; Obayashi, Koki; Tsuzuki, Shunsuke; Hata, Kenichi; Shimomura, Tatsuya; Miki, Jun; Egawa, Shin.

Prostate ; 82(1): 3-12, 2022 01.

Artigo em Inglês | MEDLINE | ID: mdl-34559410

7.

Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway.

Chen, Xiong; Yang, Guo; Liu, Miao; Quan, Zhen; Wang, Leilei; Luo, Chunli; Wu, Xiaohou; Zheng, Yongbo.

Biochem Biophys Res Commun ; 613: 53-60, 2022 07 12.

Artigo em Inglês | MEDLINE | ID: mdl-35533600

8.

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.

Manning-Geist, Beryl L; Gordhandas, Sushmita B; Giri, Dilip D; Iasonos, Alexia; Zhou, Qin; Girshman, Jeffrey; O'Cearbhaill, Roisin E; Zamarin, Dmitriy; Lichtman, Stuart M; Sabbatini, Paul J; Tew, William P; Li, Karen; McDonnell, Autumn S; Aviki, Emeline M; Chi, Dennis S; Aghajanian, Carol A; Grisham, Rachel N.

Gynecol Oncol ; 164(1): 12-17, 2022 01.

Artigo em Inglês | MEDLINE | ID: mdl-34763937

9.

Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.

Sartor, Oliver; George, Daniel; Tombal, Bertrand; Agarwal, Neeraj; Higano, Celestia S; Sternberg, Cora N; Miller, Kurt; Jiao, XiaoLong; Guo, Helen; Sandström, Per; Bruno, Amanda; Verholen, Frank; Saad, Fred; Shore, Neal.

Future Oncol ; 18(1): 35-45, 2022 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-34636627

10.

Medication adherence among patients with advanced prostate cancer using oral therapies.

Pilon, Dominic; LaMori, Joyce; Rossi, Carmine; Durkin, Mike; Ghelerter, Isabelle; Ke, Xuehua; Lafeuille, Marie-Hélène; Ellis, Lorie; Lefebvre, Patrick.

Future Oncol ; 18(2): 231-243, 2022 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-34730001

11.

Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis.

Ly, Thanh Truong Giang; Yun, Jisoo; Ha, Jong-Seong; Kim, Yeon-Ju; Jang, Woong-Bi; Van Le, Thi Hong; Rethineswaran, Vinoth Kumar; Choi, Jaewoo; Kim, Jae-Ho; Min, Sang-Hyun; Lee, Dong-Hyung; Yang, Ju-Seok; Chung, Joo-Seop; Kwon, Sang-Mo.

Int J Mol Sci ; 23(2)2022 Jan 15.

Artigo em Inglês | MEDLINE | ID: mdl-35055132

12.

Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial.

Shenderov, Eugene; Boudadi, Karim; Fu, Wei; Wang, Hao; Sullivan, Rana; Jordan, Alice; Dowling, Donna; Harb, Rana; Schonhoft, Joseph; Jendrisak, Adam; Carducci, Michael A; Eisenberger, Mario A; Eshleman, James R; Luo, Jun; Drake, Charles G; Pardoll, Drew M; Antonarakis, Emmanuel S.

Prostate ; 81(6): 326-338, 2021 05.

Artigo em Inglês | MEDLINE | ID: mdl-33636027

13.

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.

Onal, Cem; Kose, Fatih; Ozyigit, Gokhan; Aksoy, Sercan; Oymak, Ezgi; Muallaoglu, Sadik; Guler, Ozan C; Tilki, Burak; Hurmuz, Pervin; Akyol, Fadil.

Prostate ; 81(9): 543-552, 2021 06.

Artigo em Inglês | MEDLINE | ID: mdl-33905131

14.

Apalutamide radio-sensitisation of prostate cancer.

Kakouratos, Christos; Kalamida, Dimitra; Lamprou, Ioannis; Xanthopoulou, Erasmia; Nanos, Christos; Giatromanolaki, Alexandra; Koukourakis, Michael I.

Br J Cancer ; 125(10): 1377-1387, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34471256

15.

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real-life perspective.

Savani, Malvi; Dulery, Rémy; Bazarbachi, Abdul Hamid; Mohty, Razan; Brissot, Eolia; Malard, Florent; Bazarbachi, Ali; Nagler, Arnon; Mohty, Mohamad.

Br J Haematol ; 195(4): 495-506, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-33881169

16.

TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia.

Claudiani, Simone; Apperley, Jane F; Szydlo, Richard; Khan, Afzal; Nesr, George; Hayden, Chloe; J Innes, Andrew; Dominy, Kathy; Foskett, Pierre; Foroni, Letizia; Khorashad, Jamshid; Milojkovic, Dragana.

Br J Haematol ; 193(2): 346-355, 2021 04.

Artigo em Inglês | MEDLINE | ID: mdl-33368155

17.

Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.

Halabi, Susan; Jiang, Shan; Terasawa, Emi; Garcia-Horton, Viviana; Ayyagari, Rajeev; Waldeck, A Reginald; Shore, Neal.

J Urol ; 206(2): 298-307, 2021 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-33818140

18.

Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors.

Latagliata, Roberto; Attolico, Immacolata; Trawinska, Malgorzata Monika; Capodanno, Isabella; Annunziata, Mario; Elena, Chiara; Luciano, Luigiana; Crugnola, Monica; Bergamaschi, Micaela; Bonifacio, Massimiliano; Baratè, Claudia; Mauro, Endri; Binotto, Gianni; Sgherza, Nicola; Aguzzi, Chiara; Monteleone, Barbara; Sorà, Federica; Caocci, Giovanni; Luzi, Debora; Mariggiò, Elena; Scaffidi, Luigi; Cattaneo, Daniele; Gozzini, Antonella; Di Veroli, Ambra; Abruzzese, Elisabetta; Galimberti, Sara; Iurlo, Alessandra; Specchia, Giorgina; Breccia, Massimo.

Hematol Oncol ; 39(3): 401-408, 2021 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-33617659

19.

ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).

Emmett, Louise; Subramaniam, Shalini; Joshua, Anthony M; Crumbaker, Megan; Martin, Andrew; Zhang, Alison Y; Rana, Nisha; Langford, Ailsa; Mitchell, Jenna; Yip, Sonia; Francis, Roslyn; Hofman, Michael S; Sandhu, Shahneen; Azad, Arun; Gedye, Craig; McJannett, Margaret; Stockler, Martin R; Davis, Ian D.

BJU Int ; 128(5): 642-651, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34028967

20.

Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.

Cortes, Jorge E; Kantarjian, Hagop M; Mauro, Michael J; An, Fiona; Nick, Sonja; Leip, Eric; Gambacorti-Passerini, Carlo; Brümmendorf, Tim H.

Eur J Haematol ; 106(6): 808-820, 2021 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-33638218

BVS IEC

Instituto Evandro Chagas

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: